1. Home
  2. RANI vs FORA Comparison

RANI vs FORA Comparison

Compare RANI & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RANI
  • FORA
  • Stock Information
  • Founded
  • RANI 2012
  • FORA 2014
  • Country
  • RANI United States
  • FORA United States
  • Employees
  • RANI N/A
  • FORA N/A
  • Industry
  • RANI Medicinal Chemicals and Botanical Products
  • FORA Computer Software: Prepackaged Software
  • Sector
  • RANI Health Care
  • FORA Technology
  • Exchange
  • RANI Nasdaq
  • FORA Nasdaq
  • Market Cap
  • RANI 55.3M
  • FORA 62.7M
  • IPO Year
  • RANI 2021
  • FORA N/A
  • Fundamental
  • Price
  • RANI $1.23
  • FORA $1.97
  • Analyst Decision
  • RANI Strong Buy
  • FORA Strong Buy
  • Analyst Count
  • RANI 6
  • FORA 1
  • Target Price
  • RANI $11.33
  • FORA $5.00
  • AVG Volume (30 Days)
  • RANI 145.5K
  • FORA 8.8K
  • Earning Date
  • RANI 03-31-2025
  • FORA 03-27-2025
  • Dividend Yield
  • RANI N/A
  • FORA N/A
  • EPS Growth
  • RANI N/A
  • FORA N/A
  • EPS
  • RANI N/A
  • FORA N/A
  • Revenue
  • RANI N/A
  • FORA $19,709,723.00
  • Revenue This Year
  • RANI N/A
  • FORA N/A
  • Revenue Next Year
  • RANI N/A
  • FORA $13.59
  • P/E Ratio
  • RANI N/A
  • FORA N/A
  • Revenue Growth
  • RANI N/A
  • FORA N/A
  • 52 Week Low
  • RANI $1.20
  • FORA $1.90
  • 52 Week High
  • RANI $8.75
  • FORA $4.03
  • Technical
  • Relative Strength Index (RSI)
  • RANI 33.72
  • FORA 41.22
  • Support Level
  • RANI $1.30
  • FORA $2.05
  • Resistance Level
  • RANI $1.56
  • FORA $2.13
  • Average True Range (ATR)
  • RANI 0.09
  • FORA 0.10
  • MACD
  • RANI -0.03
  • FORA -0.00
  • Stochastic Oscillator
  • RANI 8.33
  • FORA 23.69

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.

About FORA Forian Inc.

Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.

Share on Social Networks: